IMP在临床试验中通常指Investigational Medicinal Product,即研究用药品。它是指正在临床试验阶段的药品,尚未获得批准上市,但已经完成了初步的实验验证和安全性评估。 发布于 2025-02-25 11:12・IP 属地上海 赞同 分享 收藏 写下你的评论... ...
(Investigational) Medicinal Product 选择语言:从中文简体中文翻译英语日语韩语俄语德语法语阿拉伯文西班牙语葡萄牙语意大利语荷兰语瑞典语希腊语捷克语丹麦语匈牙利语希伯来语波斯语挪威语乌尔都语罗马尼亚语土耳其语波兰语到中文简体中文翻译英语日语韩语俄语德语法语阿拉伯文西班牙语葡萄牙语意大利语荷兰语瑞典语希腊语捷克语...
Social Investigational Medicinal Product (IMP). A pharmaceutical form of an active substance or placebo being tested or used as a reference in a clinical trial, including products already with a marketing authorisation but used or assembled in a different way from the authorised form, or when used...
The Investigational Medicinal Product Dossier (IMPD): EU CTA vs. FDA IND: Comparing the Content and Agency Expectations 2017 (64034), organized by Compliance4All. Find webinar details | Conference Locate (Clocate)